Cetera Investment Advisers
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1666741
SCHAUMBURG, IL
Position in BMRN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$931,255
-$762,315 QoQ
Shares Held
16,275
-45.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#284
of 561 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. BMRN ranks #39 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,196 | $6,982,691 |
All Filings in BMRN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $931,255 | 16,275 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,693,570 | 29,980 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,194,333 | 36,923 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,170,678 | 40,079 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,335,551 | 24,296 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,068,035 | 29,255 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $744,326 | 11,324 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $523,941 | 7,454 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $962,602 | 11,692 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $1,401,719 | 16,049 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $483,931 | 5,019 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $426,916 | 4,825 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $397,601 | 4,587 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $343,257 | 3,530 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $359,213 | 3,471 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $262,787 | 3,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $272,559 | 3,289 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $459,438 | 5,959 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $571,624 | 6,470 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $471,469 | 6,100 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $468,682 | 5,617 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $236,324 | 2,695 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||